Tradestie Institutional Equity Comparison Engine
BNBX vs BMRA โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
BMRA Overall Edge
BMRA Captures Institutional Edge (2โ1 Pillars ยท 5โ2 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Biomerica Inc (BMRA) driven by superior Growth & Margin, Momentum & Technical while BNBX counters with relative strength in Valuation. Fundamentally, BNBX trades at N/M Forward P/E with -636.4% operating margin (+34.3% YoY revenue) versus BMRA at N/M Forward P/E and -125.2% operating margin (-8.3% YoY). In options structure, BNBX sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against BMRA sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
BNBX
BNBX N/M vs BMRA N/M Fwd P/E
Growth & Margin Winner
BMRA
Op Margin -636.4% vs -125.2% ยท YoY +34.3% vs -8.3%
Momentum & Technical Winner
BMRA
1Y -97.0% vs -46.9% ยท 52W Pos 0% vs 4%
Options & Structure Winner
Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
BNBX
US Equity
BNB Plus Corp.
Finance Services
$0.16
-56.75% 1D
Market Cap
$2.7M
1M Return
-67.4%
1Y Return
-96.95%
Forward P/E
N/M
Unified AI Score
37.7 / 100
SELL
Tech 40.0
Fund 46.0
Flow 50.0
Mom 48.9
BMRA
NASDAQ
Biomerica Inc
In Vitro & In Vivo Diagnostic Substances
$1.33
-2.32% 1D
Market Cap
$6.0M
1M Return
-28.19%
1Y Return
-46.86%
Forward P/E
N/M
Unified AI Score
44.5 / 100
HOLD
Tech 40.0
Fund 47.0
Flow 50.0
Mom 44.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
BNBX -96.95%
BMRA -46.86%
Spread: +62.36 pp (BMRA Lead)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | BNBX Revenue | BMRA Revenue | BNBX Op. Margin | BMRA Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2019 | $10M | $10M | -169.3% | -46.4% | BMRA |
| FY2020 | $0M | $10M | -649.0% | -41.0% | BMRA |
| FY2021 | $10M | $10M | -147.9% | -104.2% | BMRA |
| FY2022 | $20M | $20M | -76.9% | -24.0% | BMRA |
| FY2023 | $10M | $10M | -81.9% | -135.3% | BNBX |
| FY2024 | $0M | $10M | -646.7% | -117.6% | BMRA |
| FY2025 | $0M | $10M | -750.9% | -96.7% | BMRA |
| FY2026 | N/A | $0M | N/A | -119.5% | BMRA |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | BNBX | BMRA | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $2.7M | $6.0M | Larger Scale | Tie |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | +34.3% | -8.3% | Higher Growth | BNBX |
| Operating Margin (TTM) Profitability | -636.4% | -125.2% | Higher Margin | BMRA |
| Net Profit Margin Profitability | 0.0% | -115.5% | Higher Margin | BNBX |
| Return on Equity (ROE) Capital Efficiency | -306.8% | -113.8% | Higher ROE | BMRA |
| 52-Week Range Position Momentum | 0% ($0โ$7) | 4% ($1โ$3) | Stronger Trend | BMRA |
| Beta / 30D Volatility Risk Regime | 1.68ฮฒ ยท 227% Vol | 0.67ฮฒ ยท 62% Vol | Lower Realized Risk | BMRA |
| Unified Institutional Score Composite Signal | 37.7 / 100 (SELL) | 44.5 / 100 (HOLD) | Higher Composite | BMRA |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full BNBX vs BMRA Buy Guide
BNBX
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
BMRA
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither BNBX nor BMRA registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.